What is the DSCSA’s requirement for 503B Outsourcing Facilities regarding DSCSA documentation?

What is the DSCSA’s requirement for 503B Outsourcing Facilities regarding DSCSA documentation?

• A. These facilities are not subject to DSCSA requirements
• B. These facilities only dispense medications
• C. These facilities compound products for office use
• D. These facilities operate without any DSCSA documentation

Answer: (C)

Outsourcing facilities under the 503B category exist to compound sterile products in bulk for use in healthcare settings and then distribute them to clinics, hospitals, or office-based practices. That function—compounding for office use and supplying to facilities rather than dispensing to individual patients—is why the statement about their role is the most fitting description in the DSCSA context. The DSCSA requires traceability documentation for products moving through the supply chain, and 503B facilities do participate in that system when they distribute their compounded products. They are not exempt from DSCSA requirements, they do more than just dispense medications, and they do not operate without DSCSA documentation.

Outsourcing facilities under the 503B category exist to compound sterile products in bulk for use in healthcare settings and then distribute them to clinics, hospitals, or office-based practices. That function—compounding for office use and supplying to facilities rather than dispensing to individual patients—is why the statement about their role is the most fitting description in the DSCSA context. The DSCSA requires traceability documentation for products moving through the supply chain, and 503B facilities do participate in that system when they distribute their compounded products. They are not exempt from DSCSA requirements, they do more than just dispense medications, and they do not operate without DSCSA documentation.